haleon plc glp-1 receptor agonist medications agonists GLP-1 Agonists: A Comprehensive Overview

For you as someone considering or using these medications, the practical takeaway is straightforward

While the numbers we estimate are for Great Britain as a whole, it is noteworthy that the number using these medications for weight loss far exceeds the initial expectation for NHS England to provide treatment for 220,000 people in the first 3 years, which is likely to have important consequences for NHS budgets, although our estimate is less than the number eligible according to NICE guidelines (3.4 million) [14]

T., Kuhlmann, M., Hvam, M

GLP-1 and immune cells

Across all insurers, the numbers were sobering

doi: 10.2337/db09-9028